Wilmington, Delaware, April 23, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Point of Care Hematology Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2024-2030″, valued at $2.4 billion in 2023, is poised for significant growth. With a projected CAGR of 5.8% from 2024 to 2030, the market is expected to reach $3.6 billion by the end of 2030. The point-of-care hematology diagnostics market is driven by the rise in demand for rapid, accurate, and decentralized blood testing solutions and rise in hematological disorders.
Market Introduction
The point-of-care hematology diagnostics market focuses on diagnostic tests performed near or at the site of patient care to quickly evaluate blood-related parameters such as red and white blood cell counts, hemoglobin levels, and coagulation status. These tests are essential for the timely diagnosis and monitoring of conditions like anemia, infections, and clotting disorders, particularly in emergency settings, remote locations, and outpatient care.
The market has seen significant developments driven by the rising demand for rapid and decentralized testing, advancements in portable and automated diagnostic devices, and growing healthcare awareness. Key events shaping the market include the introduction of compact hematology analyzers, integration of AI and connectivity features, and regulatory approvals of user-friendly POC devices designed for home use and rural outreach. Companies are increasingly investing in R&D and partnerships to expand their product offerings and geographical reach, making point-of-care hematology diagnostics a critical segment in modern healthcare delivery.
Request Sample of the Report on Global Point of Care Hematology Diagnostics Market 2030 –https://www.alliedmarketresearch.com/request-sample/A325622
Report Overview
The point of care hematology diagnostics market is segmented on the basis of test type, mode of prescription, end user, and region. By test type, the market is classified into complete blood count (CBC), coagulation testing, hemoglobin testing & anemia diagnosis, and others. By mode of prescription, the market is segregated into prescription based products and OTC based products. By end user, the market is divided into diagnostic centers, hospitals, blood banks and transfusion centers, and others.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, Hungary, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and the rest of LAMEA).
- By test type, the complete blood count (CBC) segment dominated the global point of care hematology diagnostics market in 2023 and is anticipated to maintain its dominance during the forecast period. However, the coagulation testing segment is anticipated to register the highest CAGR during the forecast period.
- By mode of prescription, the prescription-based product segment dominated the global market in 2023. However, the OTC based product segment is anticipated to be the fastest-growing segment during the forecast period.
- By end user, the hospitals segment dominated the market in terms of revenue in 2023. However, the other segment is expected to register the highest CAGR during the forecast period.
- North America dominated the market in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Report Coverage & Details
| Report Coverage | Details |
| Forecast Period | 2024–2030 |
| Base Year | 2023 |
| Market Size in 2023 | $2.4 billion |
| Market Size in 2030 |